Jonathan D. Root
Director at Carlsmed; Director at Omada Health; Director at Edgewise Therapeutics. Based in South San Francisco, California.
- Rank
- 7699th of 14,644
- Companies held
- 4
- Largest holding
- CARL, 71.8% of total
- Latest SEC filing
- Oct 5, 2026
- Listed but not counted
- $102M
What the $11.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Carlsmed CARL Common Stock | Directly | 497,697 | $17.21 | $8.6M | 71.8% | Form 4, Jun 3, 2026 |
| Omada Health OMDA Common Stock | Directly | 192,571 | $12.50 | $2.4M | 20.2% | Form 4, Oct 5, 2026 |
| Edgewise Therapeutics EWTX Common Stock | Directly | 15,625 | $41.11 | $642K | 5.4% | Form 4, Feb 25, 2022 |
| ARS Pharmaceuticals SPRY Common Stock | Directly | 95,238 | $3.32 | $316K | 2.6% | Form 4, Dec 13, 2021 |
Share counts are the amounts Jonathan D. Root reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Jonathan D. Root's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Carlsmed CARL Common Stock | Through U.S. Venture Partners XII, L.P. Held by a company or fund the insider manages | 4,305,806 | $17.21 | $74.1M | — | Form 4, Jun 3, 2026 |
| Carlsmed CARL Common Stock | Through U.S. Venture Partners Select Fund I, L.P. Held by a company or fund the insider manages | 1,117,743 | $17.21 | $19.2M | — | Form 4, Jun 3, 2026 |
| Carlsmed CARL Common Stock | Indirectly (see filing footnote) Held by a company or fund the insider manages | 218,524 | $17.21 | $3.8M | — | Form 4, Jun 3, 2026 |
| Carlsmed CARL Common Stock | Through U.S. Venture Partners XII-A, L.P. Held by a company or fund the insider manages | 191,531 | $17.21 | $3.3M | — | Form 4, Jul 24, 2025 |
| Omada Health OMDA Common Stock | Through U.S. Venture Partners X, L.P. Held by a company or fund the insider manages | 146,257 | $12.50 | $1.8M | — | Form 4, Oct 5, 2025 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 7696 | Daniel P. Govin Chief Operating Officer (COO), Sterling Infrastructure. The Woodlands, TX | $11.9M |
| 7697 | Curtis L. Dinan See Remarks, ONE Gas. Tulsa, OK | $11.9M |
| 7698 | Robert M. Klein EVP, Sales, Advanced Drainage Systems. Hilliard, OH | $11.9M |
| 7699 | Jonathan D. Root Director, Carlsmed. South San Francisco, CA | $11.9M |
| 7700 | Michael F. Barry Director, Quaker Chemical. Philadelphia, PA | $11.9M |
| 7701 | Bryan H. Lawrence Director, Riley Exploration Permian. New York, NY | $11.9M |
| 7702 | Brian P. Anderson Director, PulteGroup. Davie, FL | $11.9M |
Other Carlsmed insiders
All CARL insiders- Michael Cordonnier$26.7MCEO, President. #4157 overall
- Niall Casey$16.9MChief IP Officer. #5873 overall
- Leonard Greenstein$3.2MCFO, Treasurer. #13850 overall
Questions
How much stock does Jonathan D. Root own?
Jonathan D. Root holds $11,928,072 in listed stock based on SEC filings and current prices, mostly Carlsmed (CARL). That ranks 7699th on the Stock Rich List.
Is this Jonathan D. Root's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.